Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Cytokine1 who wrote (4257)	3/7/1998 4:56:00 PM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 9719

Cytokine, here is the list of companies in BTK (from amex.com ): Index ComponentsThe Biotechnology Index is composed of shares of the following issues:ÿAdvanced Tissue Life Sciences(ATIS)Genzyme Corporation (GENZ)ÿAmgen Inc. (AMGN)Gilead Sciences Inc. (GILD)ÿBiogen, Inc.(BGEN)Immune Response Corporation(IMNR)ÿBio-Technology General Corp.(BTGC)Immunex Corporation(IMNX)ÿCentocor Inc. (CNTO)Organogenesis Inc. (ORG)ÿCephalon, Inc. (CEPH)Protein Design Labs, Inc. (PDLI)ÿChiron Corporation (CHIR)Vertex Pharmaceuticals, Inc.(VRTX)ÿCOR Therapeutics, Inc. (CORR)ÿ In theory, IXB is more representative, but in practice, because it is capitalization-weighted (BTK is readjusted every quarter to keep it dollar-weighted), it ends up reflecting Amgen, Genzyme, Biogen and little else. OTOH since BTK has so few companies good or bad news in a given company, for example CORR a few weeks ago, can have a huge effect. I find both indices useful. PB